Toxicity OF Fluoropyrimidines: A Comparative Study of the Cardiotoxicity of capEcitabine and tEysuno
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Capecitabine; Oxaliplatin
- Indications Colorectal cancer; Gastric cancer; Liver cancer; Oesophageal cancer; Pancreatic cancer
- Focus Adverse reactions
- Acronyms TOFFEE
- 09 Dec 2015 Planned End Date changed from 5 Jan 2015 to 30 Dec 2017 as reported by United Kingdom Clinical Research Network record.
- 13 Jun 2015 Planned End Date changed from 5 Sep 2015 to 5 Jan 2015 as reported by United Kingdom Clinical Research Network record.
- 15 Nov 2014 Accrual to Date is 13% according to United Kingdom Clinical Research Network.